Blog

Jan 2023

How the Premortem Can Improve the Success of Clinical Trials

By |2023-01-24T11:30:18+02:00January 24, 2023|Blog, News|Comments Off on How the Premortem Can Improve the Success of Clinical Trials

Learn about the high failure rate of clinical trials & how the premortem approach can improve success by identifying potential problems early. Discover how this technique can foster a culture of collaboration & learning within the team, reducing the need for a painful postmortem.

Jan 2023

Our RBQM Solution Recognized by Microsoft: Achieving High Data Quality in Clinical Trials

By |2023-01-18T16:19:56+02:00January 18, 2023|Blog, News|Comments Off on Our RBQM Solution Recognized by Microsoft: Achieving High Data Quality in Clinical Trials

At Cyntegrity, we're on a mission to deliver the highest possible data quality in clinical trials. That's why we're thrilled to have been recognized by Microsoft as a valuable use case. Don't miss out on reading how we're making a difference in the biopharma industry by checking out our customer story on Microsoft's website.

Nov 2022

Cyntegrity at Metropolitan School Frankfurt

By |2022-11-17T13:43:56+02:00November 9, 2022|Blog, Butterfly Challenge, News|Comments Off on Cyntegrity at Metropolitan School Frankfurt

On the wings of the Butterfly Challenge, our CEO Artem Andrianov and Junior Data Scientist Ting-Yu Ho shared their scientific knowledge with 10th graders helping them acquire real-world vision.

Jun 2022

Milestone | We Have Just Successfully Completed SOC 2 Examination

By |2022-10-18T15:48:09+02:00June 27, 2022|Blog, News|Comments Off on Milestone | We Have Just Successfully Completed SOC 2 Examination

Today we are proud to announce another milestone for our organization. Being SOC 2 Type 1 compliant means, we have successfully maintained effective controls over our online cloud platforms' security, availability, and confidentiality. In other words, you can rest easy knowing your data is safe with us.

Jun 2022

Why Standards Matter in Clinical Research

By |2022-06-20T08:59:51+02:00June 20, 2022|Blog|Comments Off on Why Standards Matter in Clinical Research

The so-called "cucumber regulation" may mean nothing to you. However, it guarantees comparable products to retailers, consumers, and processors across Europe, a standard. Standardization drives quality over time and develops global trust. Do we have standards in clinical research? Yes, but not enough, and they may not always be adhered to.

Oct 2021

Milestone | We Have Just Received our ISO 9001:2015 Certificate

By |2021-11-02T06:29:03+02:00October 26, 2021|Blog, News|Comments Off on Milestone | We Have Just Received our ISO 9001:2015 Certificate

Today we are proud to announce another milestone for our organization. Being ISO certified means that our QMS drives the three key principles of ISO 9001.

Oct 2021

Quality by Design | ICH E8(R1) General Considerations for Clinical Studies

By |2022-04-25T10:15:06+02:00October 17, 2021|Blog, Free Infographics|Comments Off on Quality by Design | ICH E8(R1) General Considerations for Clinical Studies

The final version of the ICH E8(R1) guidance discourages the old-school "one size fits all" approach. Instead, risk-based quality management concepts such as QbD and CtQ factors predominate these modern-day considerations which encourage the biopharma industry to go beyond the traditional checklists. We've visualized the final 2021 guidance, "General Considerations for Clinical Studies," for you.

Sep 2021

Risks of IMP Management Under Standard vs. Pandemic Conditions

By |2021-12-22T16:59:18+02:00September 30, 2021|Blog, Case Studies|Comments Off on Risks of IMP Management Under Standard vs. Pandemic Conditions

The COVID-19 pandemic has accelerated alternative distribution strategy adoption to facilitate “new normal” decentralized and hybrid trial concepts. Capturing the IMP supply chain risks associated with these more flexible distribution approaches requires synergy among people, processes, and technology. Former Senior Project Manager at GKM, Anke Mueller, shares with you how pandemic-induced supply chain risk data knitted together in a single RAC tool enabled her study team to pivot quickly and continue their studies in a timely fashion.

Go to Top